The goal of the ACGME-accredited vascular neurology educational program at NINDS/NIH is to cultivate an environment that facilitates learning through didactic and clinical experiences and provides trainees with the requisite skills necessary to become an academic vascular neurologist. The vascular neurology fellowship program provides trainees with a broad-based clinical experience, an extensive series of lectures and seminars, opportunities to participate in research and scholarly activities, and career counseling and mentoring.
The educational program consists of a core curriculum that contains essential basic and clinical science training that enables each resident to be proficient in field of vascular neurology. Our faculty is dedicated to patient care, teaching, scholarship, research, and intellectual interest and provides the infrastructure and training for the vascular neurology resident. The faculty utilizes a teaching approach that fosters student enthusiasm, critical thinking, and commitment to lifelong learning.
The program offers a one-year ACGME accredited fellowship with the opportunity to extend the fellowship for additional years of research-focused training for those interested in an academic or research track.
The clinical and research activities of the NIH Stroke Program take place at the NIH Clinical Center, Suburban Hospital (a 239-bed community hospital and a member of Johns Hopkins Medicine located directly across from the NIH Campus), and Washington Hospital Center (a 926-bed academic medical center located in Washington, DC). This unique program provides trainees with an opportunity to evaluate and manage patients in academic, research, and community hospital settings while providing access to greater diversity in disease etiology.
The NIH stroke program research seeks to make scientific advances for new acute stroke and secondary prevention therapies. Areas of current research include the following:
• MRI-guided enhancement of diagnosis and management of Acute Stroke
• Supplementary measures to augment the efficacy, safety, and appropriate use of tPA and endovascular treatments
• Blood-Brain barrier disruption in people with white matter hyperintensities who have had a stroke
• Evaluation, Pathogenesis, and Treatment of Patients with or at Risk for Cerebrovascular Disease
FACULTY AND GME PAGE
Malik Adil, M.D., Director, Suburban Hospital – Johns Hopkins Medicine, Stroke Program
Amie Hsia, M.D., Medical Director, MedStar Washington Hospital Center, Stroke Program
Yongwoo Kim, M.D., Vascular Neurologist, MedStar Washington Hospital Center, Stroke Program